Small Molecules

07 Mar 2007 Replidyne Phase II Pediatric Trial Meets Primary Objective
07 Mar 2007 Sunesis Initiates Phase 1 Clinical Trial of SNS-032 in Patients With B-cell Malignancies
07 Mar 2007 Cytochroma Completes Enrollment In Phase II Psoriasis Trial
07 Mar 2007 Wyeth and Progenics to Begin Clinical Testing of a New Formulation of Oral Methylnaltrexone Based on Phase 2 Findings
07 Mar 2007 Savient Announces Completion of Patient Enrollment in Phase 3 Trials of Puricase(R) for Treatment-Failure Gout
06 Mar 2007 Memory Pharmaceuticals Reports Phase 2a Results for MEM 1003 in Bipolar Disorder
06 Mar 2007 Neoprobe Announces Interim Phase 2 Lymphoseek Results
06 Mar 2007 Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
06 Mar 2007 Arena Pharmaceuticals Initiates Phase 2 Clinical Trial of APD125 for the Treatment of Insomnia
06 Mar 2007 LAB International Announces Positive Results From The Open-Label Phase IIB Fentanyl Taifun(R) Trial
06 Mar 2007 AD 923 Commences Phase 1 Clinical Development in the USA
06 Mar 2007 AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex
06 Mar 2007 Actelion: Positive Study With Bosentan (Tracleer) in CTEPH
06 Mar 2007 Biocryst And Shionogi Establish Collaboration In Japan
06 Mar 2007 YM BioSciences completes enrolment of AeroLEF(TM) Phase IIB pain trial
03 Mar 2007 Sebivo(R) approved in China for treatment of chronic hepatitis B, the nation's second leading cause of death
03 Mar 2007 FDA Approves Astellas' Vaprisol for the Treatment of Hypervolemic Hyponatremia
03 Mar 2007 Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
02 Mar 2007 Pfizer's Maraviroc, Novel Medicine For HIV, Significantly Reduces Viral Load, in Combination Therapy Across Range of Treatment-Experienced Patients
02 Mar 2007 Sunesis Pharmaceuticals Files Investigational New Drug Application for Novel Aurora Kinase Inhibitor, SNS-314
02 Mar 2007 EMEA Accepts for Review Thalidomide Pharmion(R) Marketing Authorization Application for Untreated Multiple Myeloma
02 Mar 2007 Insert Therapeutics Signs New Partnership With R&D Biopharmaceuticals
02 Mar 2007 KeyNeurotek AG and Grünenthal GmbH sign exclusive licensing agreement for drug development and marketing
02 Mar 2007 Point Therapeutics Provides Clinical Update
02 Mar 2007 CollaGenex Pharmaceuticals Announces Positive Results of Phase 2 Dose-Finding Study of Incyclinide for the Treatment of Acne

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up